Blog - FreeMind Group

Everybody 12 /Case Studies 0 /Conferences 9 /FreeMind Elite 0 /FreeMind Elite 2024 0 /Job posting 0 /NDFS 2025 Presentations 0 /News 3 /Opinions 0 /Opportunities 0 /Presentations 0 /Uncategorized 0 /Webinars 0

RESI Boston Social Graphic for FreeMind — RESI, September 17, 2025, Boston
July 14, 2025/by Ayal Ronen

Asia Bio Partnering Forum_1200x627 -100 — Asia Bio Partnering Forum, September 9-10, 2025, Singapore
July 14, 2025/by Ayal Ronen

Obesity Science Innovation – Media Partner Banner — Obesity Science & Innovation, September 16-17, 2025, Boston
July 14, 2025/by Ayal Ronen

LSX USA 2025 Ingo Supporting — LSX USA Congress, September 16-17, 2025, Boston
July 14, 2025/by Ayal Ronen

MM Freemind Social (002) — LSX RNA Leaders, September 10-11, 2025, Boston
July 14, 2025/by Ayal Ronen

DOGE Loses Control Over Federal Grants — A Turning Point in U.S. Grant-Making — DOGE Loses Control Over Federal Grants — A Turning Point in U.S. Grant-Making
June 30, 2025/by Ayal Ronen

Navigating FY26 Budget Proposal — Analyzing the FY26 White House Budget-in-Brief Impact on Life Science R&D Companies
June 3, 2025/by Ayal Ronen

RESI Boston June 2025 Media Partner Promotion (FreeMind) (002) — RESI, June 16, 2025, Boston
May 20, 2025/by Ayal Ronen

meta-image-1200×630 — HLTH Europe June 16-19, 2025, Amsterdam
May 20, 2025/by Ayal Ronen

Sachs Obesity EU — Sachs European Biopharma Obesity Innovation Forum, June 11-12, 2025, Leipzig
May 20, 2025/by Ayal Ronen

AET EU FREEMIND Banner — Informa Antibody Engineering & Therapeutics, June 10-12, 2025, Basel
May 18, 2025/by Ayal Ronen

SBIR Reautherization 2025 — The SBIR/STTR Reauthorization Act of 2025: Investing in Small Business Innovation and Entrepreneurship
May 7, 2025/by Ayal Ronen

Reach out to us with your non-dilutive funding requirements

Contact us Who we are

Subscribe to our Newsletter